The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Diabetic retinopathy - ocular complications of diabetes mellitus
Open accessAbstract
In industrialized nations diabetic retinopathy is the most frequent microvascular complication of diabetes mellitus and the most common cause of blindness in the working-age population. In the next 15 years, the number of patients suffering from diabetes mellitus is expected to increase significantly. By the year 2030, about 440 million people in the age-group 20-79 years are estimated to be suffering from diabetes mellitus worldwide (prevalence 7.7%), while in 2010 there were 285 million people with diabetes mellitus (prevalence 6.4%). This accounts for an increase in patients with diabetes in industrialized nations by 20% and in developing countries by 69% until the year 2030. Due to the expected rise in diabetic patients, the need for ophthalmic care of patients (i.e., exams and treatments) will also increase and represents a challenge for eye-care providers. Development of optimized screening programs, which respect available resources of the ophthalmic infrastructure, will become even more important. Main reasons for loss of vision in patients with diabetes mellitus are diabetic macular edema and proliferative diabetic retinopathy. Incidence or progression of these potentially blinding complications can be greatly reduced by adequate control of blood glucose and blood pressure levels. Additionally, regular ophthalmic exams are mandatory for detecting ocular complications and initiating treatments such as laser photocoagulation in case of clinical significant diabetic macular edema or early proliferative diabetic retinopathy. In this way, the risk of blindness can considerably be reduced. In advanced stages of diabetic retinopathy, pars-plana vitrectomy is performed to treat vitreous hemorrhage and tractional retinal detachment. In recent years, the advent of intravitreal medication has improved therapeutic options for patients with advanced diabetic macular edema.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
Global estimates of the prevalence of diabetes for 2010 and 2030
Shaw, J. E., Sicree, R. A., & Zimmet, P. Z. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.10.007 · Cited by 7,216
Gupta, A., & Uribarri, J. (2016) · Hormone Research in Paediatrics · doi:10.1159/000444053 · Cited by 4,006
Stearne, M. R., Palmer, S. L., Hammersley, M. S., Franklin, S. L., Spivey, R. S., Lévy, J., Tidy, C. R., Bell, N. J., Steemson, J., Barrow, B. A., et al. (1998) · UCL Discovery (University College London) · Cited by 1,406
Mitchell, P., Bandello, F., Schmidt-Erfurth, U., Lang, G. E., Massin, P., Schlingemann, R. O., Sutter, F., Simader, C., Burian, G., Gerstner, O., et al. (2011) · Ophthalmology · doi:10.1016/j.ophtha.2011.01.031 · Cited by 1,326
The Diabetes Control and Complications Trial Research Group (1995) · Diabetes · doi:10.2337/diab.44.8.968 · Cited by 1,301
Boyer, D. S., Yoon, Y. H., Belfort, R., Bandello, F., Maturi, R. K., Augustin, A. J., Li, X.-Y., Cui, H., Hashad, Y., & Whitcup, S. M. (2014) · Ophthalmology · doi:10.1016/j.ophtha.2014.04.024 · Cited by 1,122
Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes
Chaturvedi, N., Sjolie, A.-K., Stephenson, J. M., Abrahamian, H., Keipes, M., Castellarin, A., Rogulja-Pepeonik, Z., & Fuller, J. H. (1998) · The Lancet · doi:10.1016/s0140-6736(97)06209-0 · Cited by 743
Klaassen, I., Van Noorden, C. J. F., & Schlingemann, R. O. (2013) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2013.02.001 · Cited by 722
A Method of Photographing Fluorescence in Circulating Blood in the Human Retina
NOVOTNY, H. R., & ALVIS, D. L. (1961) · Circulation · doi:10.1161/01.cir.24.1.82 · Cited by 698
Diabetic Macular Edema: Pathogenesis and Treatment
Bhagat, N., Grigorian, R. A., Tutela, A., & Zarbin, M. A. (2009) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2008.10.001 · Cited by 571
Campochiaro, P. A., Brown, D. M., Pearson, A., Chen, S., Boyer, D., Ruiz-Moreno, J., Garretson, B., Gupta, A., Hariprasad, S. M., Bailey, C., et al. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2012.04.030 · Cited by 517
VEGF-initiated blood-retinal barrier breakdown in early diabetes.
Qaum, T., Xu, Q., Joussen, A. M., Clemens, M. W., Qin, W., Miyamoto, K., Hasséssian, H., Wiegand, S. J., Rudge, J. S., Yancopoulos, G. D., et al. (2001) · PubMed · Cited by 508
Chaturvedi, N., Porta, M., Klein, R., Orchard, T., Fuller, J., Parving, H. H., Bilous, R., & Sjølie, A. K. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61412-9 · Cited by 451
Sjølie, A. K., Klein, R., Porta, M., Orchard, T., Fuller, J., Parving, H. H., Bilous, R., & Chaturvedi, N. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61411-7 · Cited by 435
ULTRA–WIDE-FIELD ANGIOGRAPHY IMPROVES THE DETECTION AND CLASSIFICATION OF DIABETIC RETINOPATHY
Wessel, M. M., Aaker, G. D., Parlitsis, G., Cho, M., D'Amico, D. J., & Kiss, S. (2012) · Retina · doi:10.1097/iae.0b013e3182278b64 · Cited by 359
Screening and prevention of diabetic blindness
Stefánsson, E., Bek, T., Porta, M., Larsen, N., Kristinsson, J. K., & Agardh, E. (2000) · Acta Ophthalmologica Scandinavica · doi:10.1034/j.1600-0420.2000.078004374.x · Cited by 292
Diabetic retinopathy: loss of neuroretinal adaptation to the diabetic metabolic environment
Abcouwer, S. F., & Gardner, T. W. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12412 · Cited by 254
Kramer, C. K., Rodrigues, T. C., Canani, L. H., Gross, J. L., & Azevedo, M. J. (2011) · Diabetes Care · doi:10.2337/dc11-0079 · Cited by 244
Silva, P. S., Cavallerano, J. D., Sun, J. K., Noble, J., Aiello, L. M., & Aiello, L. P. (2012) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2012.03.019 · Cited by 220
Epidemiology of Major Eye Diseases Leading to Blindness in Europe: A Literature Review
Prokofyeva, E., & Zrenner, E. (2012) · Ophthalmic Research · doi:10.1159/000329603 · Cited by 212
Aspelund, T., Þórisdóttir, Ó., Ólafsdottir, E., Gudmundsdottir, A., Einarsdóttir, A. B., Mehlsen, J., Einarsson, S., Pálsson, Ó., Einarsson, G., Bek, T., et al. (2011) · Diabetologia · doi:10.1007/s00125-011-2257-7 · Cited by 167
Diabetic retinopathy – Biomolecules and multiple pathophysiology
Ahsan, H. (2014) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2014.09.011 · Cited by 122
Biennial eye screening in patients with diabetes without retinopathy: 10-year experience
Ólafsdóttir, E., & Stefánsson, E. (2007) · British Journal of Ophthalmology · doi:10.1136/bjo.2007.123810 · Cited by 114
Kernt, M., Hadi, I., Pinter, F., Seidensticker, F., Hirneiß, C., Haritoglou, C., Kampik, A., ULBIG, M. W., & Neubauer, A. S. (2012) · Diabetes Care · doi:10.2337/dc12-0346 · Cited by 111
Dexamethasone Intravitreal Implant for Treatment of Patients with Persistent Diabetic Macular Edema
Dutra-Medeiros, M., Postorino, M., Navarro, R., García‐Arumí, J., Mateo, C., & Corcóstegui, B. (2013) · Ophthalmologica · doi:10.1159/000356413 · Cited by 97
Anti-VEGF Therapy for Diabetic Macular Edema
Stewart, M. W. (2014) · Current Diabetes Reports · doi:10.1007/s11892-014-0510-4 · Cited by 86
Tabandeh, H., Boscia, F., Sborgia, A., Ciracì, L., Dayani, P. N., Mariotti, C., Furino, C., & Flynn, H. W. (2013) · Retina · doi:10.1097/iae.0000000000000008 · Cited by 84
Anti-VEGF for the Management of Diabetic Macular Edema
Stefanini, F. R., Badaró, E., Falabella, P., Koss, M., Farah, M. E., & Maia, M. (2014) · Journal of Immunology Research · doi:10.1155/2014/632307 · Cited by 81
on behalf of the Scottish Diabetes Research Network (SDRN) Epidemiology Group and the Scottish Diabetic Retinopathy Collaborative, Looker, H. C., Nyangoma, S. O., Cromie, D. T., Olson, J. A., Leese, G. P., Philip, S., Black, M. W., Doig, J., Lee, N., et al. (2013) · Diabetologia · doi:10.1007/s00125-013-2928-7 · Cited by 80
Screening intervals for diabetic retinopathy and incidence of visual loss: a systematic review
Echouffo-Tcheugui, J. B., Ali, M. K., Roglić, G., Hayward, R. A., & Narayan, K. M. V. (2013) · Diabetic Medicine · doi:10.1111/dme.12274 · Cited by 77
Metabolic Control and Diabetic Retinopathy
Rodriguez-Fontal, M., Kerrison, J. B., Alfaro, D. V., & Jablon, E. P. (2009) · Current Diabetes Reviews · doi:10.2174/157339909787314176 · Cited by 68
NO CASES OF ENDOPHTHALMITIS AFTER 20,293 INTRAVITREAL INJECTIONS IN AN OPERATING ROOM SETTING
Brynskov, T., Kemp, H., & Sørensen, T. L. (2013) · Retina · doi:10.1097/iae.0000000000000071 · Cited by 67
RISK FACTORS FOR PROLIFERATIVE DIABETIC RETINOPATHY IN A LATINO AMERICAN POPULATION
Nittala, M. G., Keane, P. A., Zhang, K., & Sadda, S. R. (2014) · Retina · doi:10.1097/iae.0000000000000117 · Cited by 55
Kramer, C. K., & Retnakaran, R. R. (2013) · Diabetic Medicine · doi:10.1111/dme.12296 · Cited by 54
ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION
Nentwich, M. M., Yactayo-Miranda, Y., Schwarzbach, F., Wolf, A., Kampik, A., & de Kaspar, H. M. (2013) · Retina · doi:10.1097/iae.0000000000000011 · Cited by 50
Self-citationYang, J. Y., Kim, N. K., Lee, Y. J., Noh, J. H., Kim, D. J., Ko, K. S., Rhee, B. D., & Kim, D. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.10.016 · Cited by 48
The Kallikrein-Kinin System in Diabetic Retinopathy
Bhat, M., Pouliot, M., Couture, R., & Vaucher, E. (2014) · Springer eBooks · doi:10.1007/978-3-319-06683-7_5 · Cited by 41
Karlberg, C., Klein, C. F., Green, A., Sjølie, A. K., & Grauslund, J. (2011) · Acta Diabetologica · doi:10.1007/s00592-011-0304-y · Cited by 36
Nicotine Accelerates Diabetes-Induced Retinal Changes
Boretsky, A. R., Gupta, P. K., Tirgan, N., Liu, R., Godley, B. F., Zhang, W., Tilton, R. G., & Motamedi, M. (2014) · Current Eye Research · doi:10.3109/02713683.2014.924147 · Cited by 31
Chin, E. K., Sedeek, R. W., Li, Y., Beckett, L. A., Redenbo, E., Chandra, K., & Park, S. S. (2011) · Ophthalmic surgery, lasers & imaging retina · doi:10.3928/15428877-20111222-02 · Cited by 30
Is Smoking a Risk Factor for Proliferative Diabetic Retinopathy in Type 1 Diabetes?
Thorlund, M. G., Madsen, M., Green, A., Sjølie, A. K., & Grauslund, J. (2013) · Ophthalmologica · doi:10.1159/000350813 · Cited by 28
Liegl, R. G.-H., Liegl, K., Ćeklić, L., et al. (2013) · Ophthalmologica · doi:10.1159/000355092 · Cited by 24
Optimal treatment of diabetic retinopathy
Hammes, H. (2013) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018813477886 · Cited by 24
Bacterial Contamination of Needle Points after Intravitreal Injection
Nentwich, M. M., Yactayo-Miranda, Y., Weimann, S., Fröhlich, S. J., Wolf, A., Kampik, A., & de Kaspar, H. M. (2009) · European Journal of Ophthalmology · doi:10.1177/112067210901900215 · Cited by 19
Self-citationNeuroretinal Degeneration in Relation to Vasculopathy in Diabetes
Verbraak, F. D. (2014) · Diabetes · doi:10.2337/db14-0888 · Cited by 17
The Therapeutic Potential of Intraocular Depot Steroid Systems
Nentwich, M. M., & ULBIG, M. W. (2012) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2012.0584 · Cited by 8
Self-citationGinés, J., Nentwich, M. M., Bedoya, A. H. P., Cibils, P., Esteche, A., Laspina, F., Samudio, M., Fariña, N., & de Kaspar, H. M. (2012) · Der Ophthalmologe · doi:10.1007/s00347-012-2591-2 · Cited by 7
Self-citationDiabetische Makulopathie und Retinopathie
Garweg, J. G., & Wenzel, A. (2010) · Der Ophthalmologe · doi:10.1007/s00347-010-2176-x · Cited by 5
Cited by
Twarda-Clapa, A., Olczak, A., Białkowska, A. M., & Koziołkiewicz, M. (2022) · Cells · doi:10.3390/cells11081312 · Cited by 746
Altmann, C., & Schmidt, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010110 · Cited by 402
Lo, J., Yu, T. T., Ma, D., Zang, P., Owen, J. P., Zhang, Q., Wang, R. K., Beg, M. F., Lee, A. Y., Jia, Y., et al. (2021) · Ophthalmology Science · doi:10.1016/j.xops.2021.100069 · Cited by 105
Li, Y., Bai, Y.-J., Jiang, Y.-R., Yu, W.-Z., Shi, X., Chen, L., Feng, J., & Sun, G.-B. (2018) · BioMed Research International · doi:10.1155/2018/3242574 · Cited by 34
RetractedLiu, W., Tzeng, T.-F., & Liu, I.-M. (2016) · Molecules · doi:10.3390/molecules21121708 · Cited by 30
Metadata
- Authors
- Nentwich, M. M.
- Venue
- World Journal of Diabetes
- Publisher
- Baishideng Publishing Group Inc.
- Published
- 2015
- Volume
- 6
- Issue
- 3
- Pages
- 489
- ISSN
- 1948-9358 (ISSN-L)
- OpenAlex
- W2093620952
- Cited by
- 553
- References
- 54
- FWCI
- 31.26
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.